亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Method of Extracting Neural Stem Cells Using Nanoparticles

总结
This invention relates to a method of extracting biological cells from a subject, particularly, but not exclusively, a method of extracting neural stem cells from a living subject.
技术优势
Safely extracting neural stem cells from a living subject
技术应用
This technology though in an early stage of development, may give exciting potentials in biological and clinical applications, particularly in the area of regenerative medicinal treatment, from bench to bed.
详细技术说明
A method of extracting neural stem cells from a living subject, comprising the steps of introducing magnetic nanoparticles into the subject, targeting the neural stem cells with the magnetic nanoparticles to form magnetic nanoparticle-targeted cells, isolating the magnetic nanoparticle-targeted cells, extracting the magnetic nanoparticles-targeted cells from the subject.
附加资料
Inventor: CHEAH, Songeng, Kathryn | ZHANG, Linchyngjian, Janet
Priority Number: WO2006010323A1
IPC Current: C12N000500
Assignee Applicant: The University of Hong Kong
Title: PROCOLLAGEN IIA DEFICIENT MICE | SOURIS DEFICIENTE EN PROCOLAGENE IIA
Usefulness: PROCOLLAGEN IIA DEFICIENT MICE | SOURIS DEFICIENTE EN PROCOLAGENE IIA
Summary: (M1) is useful for producing mutant Col2A-1 transgenic mouse. (M2) is useful for producing a mutant mouse. (I) is useful for screening agents for treatment of a selected cardiac disorder, where the selected cardiac disorders include sudden cardiac death, cardiomegaly, cardiomyocyte, hypertrophy, cellular disarray, pulmonary hypertension with right ventricular hypertrophy, and valvular fibrosis (all claimed). (M1) is useful for screening potential drugs against ventricular remodeling, malignant arrhythmias, and congenital heart disease.
Novelty: Producing mutant procollagen IIA (Col2A-1) transgenic mouse, by introducing selected mouse embryonic stem cells having mutant Col2A-1 transgene into mouse blastocysts, and crossing chimeric founder transgenic mouse with wild-type mouse
申请日期
2013.03.15
申请号码
US 13/834,750
其他
Filed
ID号码
A61/YK/Vivo/US01
国家/地区
香港

欲了解更多信息,请点击 这里
移动设备